Daniel GoldmanSell
ARWR · Transaction Jan 31, 2023 · Filed Feb 24, 2023 · $1,001 to $15,000
NASDAQ NMS - GLOBAL MARKET · ARWR
-2.99% · -$2.68 · Vol 1.7M
After hours · updated 16:00:29 ET
Arrowhead Pharmaceuticals Inc
Biotechnology
$86.91
Veridion Score
BETALOW CONF · 6/6 factorsTue Aug 4 · last completed session · Markets closed · resumes Thu 9:30 ET · ARWR
MethodologyARWR
Arrowhead Pharmaceuticals Inc
Tue Aug 4 · last completed session · Markets closed · resumes Thu 9:30 ET
SELL BIAS
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
44/ 100
Veridion Score
SELL BIAS · LOW confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 6/6 factors with data · Tue Aug 4 · last completed session · Markets closed · resumes Thu 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is ARWR moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Arrowhead Pharmaceuticals Inc
PHARMACEUTICAL PREPARATIONSListed since
1995
Employees
711
Country
US
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$87.49
Day high
$90.81
Day low
$85.97
Previous close
$89.59
52W high
$90.81
-4.29% from high
52W low
$16.06
95% of range
Market cap
$12.6B
P/E
111.42×
EPS
$0.7800
Beta
1.47
Shares out
140.9M
Volume
1.7M
0.60× rel vol
Avg volume
2.8M
VWAP
$87.93
Price history computed in-house
1W
+0.80%
1M
+0.42%
3M
+11.49%
1Y
+427.69%
YTD
+30.91%
SMA 50 $79.23 · above
SMA 200 $65.69 · above
52W position 95%
ARWR overview
Veridion Score
44
6 of 6 factors measured
Congress receipts
1
Daniel Goldman · Sale
13F holders
None on file
Related filings and maps
Public disclosures
Congress activity in ARWR
Official filing ↗
Federal contracts
ARWR contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ARWR in this window.
Lobbying spend
ARWR lobbying filings, year to date.
Registered lobbying filings matched to Arrowhead Pharmaceuticals Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ARWR in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for ARWR.
Options
Sovereign unlock shows live options positioning for ARWR.